MarketPeel
Insider Trading Intelligence
GB

Gail Boudreaux

ELV
PRESIDENT AND CEO · ELEVANCE HEALTH, INC. · CIK 0001287920
FILING MIX · LIFETIME69%/31%
BUYS
29
SELLS
13
TOTAL VALUE
$45.08M
COMPANIES
3
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
193,186
AVG SELL PX
$462.53
TRADE KIND
SHOWING 42 / 42
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Gail Boudreaux, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+33.33%+4.88%-0.68%+5.56%+6.94%
14d9+0.00%+2.30%-4.79%+7.09%+10.61%
30d9+33.33%+8.96%+1.55%+7.41%+6.55%
60d9+33.33%+8.72%+3.57%+5.15%+4.37%
90d9+100.00%-2.25%+5.45%-7.70%-21.75%
180d9+100.00%-4.17%+8.96%-13.13%-31.97%
1y9(3 pending)+100.00%-44.09%+14.45%-58.54%-58.54%
2y9(9 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ELV · 169,251 shares · as of Mar 3, 2026
042,74785,494128,240170,9872023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 29 buys / 13 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TGT
TARGET CORP
PURCHASEGRANT
Stock grant
2,68212,192Mar 11, 2026Mar 13, 2026View →
ELV
ELEVANCE HEALTH, INC.
SALE
President and CEO
1,736$284.03$493.1K169,251Mar 3, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
63,81863,818Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
SALE
President and CEO
6,713$294.07$1.97M144,307Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
16,153160,460Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
10,527170,987Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASE
President and CEO
5,116$287.12$1.47M149,970Jul 18, 2025Jul 18, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASE
President and CEO
2,334$286.07$667.7K144,854Jul 18, 2025Jul 18, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASE
President and CEO
1,050$287.96$302.4K151,020Jul 18, 2025Jul 18, 2025View →
TGT
TARGET CORP
PURCHASEGRANT
Stock grant
2,9469,067Mar 12, 2025Mar 14, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
15,587142,520Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
SALE
President and CEO
10,396$395.50$4.11M116,313Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
10,620126,933Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
40,42940,429Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
SALE10b5-1
10b5-1 plan
1,100$498.50$548.4K159,609Jul 22, 2024Jul 23, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE10b5-1
10b5-1 plan
20,779$500.36$10.40M138,830Jul 22, 2024Jul 23, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE10b5-1
10b5-1 plan
2,250$504.27$1.13M126,709Jul 22, 2024Jul 23, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE10b5-1
10b5-1 plan
2,250$502.23$1.13M129,959Jul 22, 2024Jul 23, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE10b5-1
10b5-1 plan
1,000$503.67$503.7K128,959Jul 22, 2024Jul 23, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE10b5-1
10b5-1 plan
6,621$501.40$3.32M132,209Jul 22, 2024Jul 23, 2024View →
TGT
TARGET CORP
PURCHASEGRANT
Stock grant
1,8735,918Mar 13, 2024Mar 15, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
32,48032,480Mar 1, 2024Mar 5, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
34,517160,709Mar 1, 2024Mar 5, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
President and CEO
19,256$499.11$9.61M117,777Mar 1, 2024Mar 5, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
8,415126,192Mar 1, 2024Mar 5, 2024View →
TGT
TARGET CORP
PURCHASEGRANT
Stock grant
1,9023,896Mar 8, 2023Mar 10, 2023View →
ELV
ELEVANCE HEALTH, INC.
SALE
President and CEO
17,614$468.78$8.26M135,863Mar 2, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
SALE
President and CEO
2,471$469.03$1.16M109,180Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
35,875153,477Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
32,38032,380Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
8,422117,602Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
SALEGRANT
Gift
10,000111,415Nov 4, 2022Nov 4, 2022View →
TGT
TARGET CORP
PURCHASEGRANT
Stock grant
1,4321,949Mar 9, 2022Mar 10, 2022View →
TGT
TARGET CORP
PURCHASEGRANT
Stock grant
514514Sep 23, 2021Sep 24, 2021View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
169.78511,743.19Mar 31, 2021Apr 2, 2021View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
179.89111,555.713Dec 31, 2020Jan 5, 2021View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
202.56311,355.245Sep 30, 2020Oct 2, 2020View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
232.30311,133.374Jun 30, 2020Jul 2, 2020View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,077.2299,441.11May 8, 2020May 12, 2020View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
50010,901.071May 8, 2020May 12, 2020View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
277.72210,380.968Mar 31, 2020Apr 2, 2020View →
ZBH
ZIMMER BIOMET HOLDINGS, INC.
PURCHASEGRANT
Stock grant
184.56410,087.316Dec 31, 2019Jan 3, 2020View →
Other insiders · ELV
Loading peer insiders…
About this filer
CIK 0001287920
ROLE
President and CEO
PRIMARY
ELV
COMPANIES
3
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001287920DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback